Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
University Children's Hospital, |
RCV000235505 | SCV000262811 | pathogenic | Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency | criteria provided, single submitter | clinical testing | ||
Fulgent Genetics, |
RCV000235505 | SCV002792389 | pathogenic | Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency | 2022-01-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002515557 | SCV003439354 | pathogenic | not provided | 2024-01-04 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln659*) in the MUT gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MUT are known to be pathogenic (PMID: 15781192). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with methylmalonic aciduria (PMID: 27167370, 27233228). ClinVar contains an entry for this variant (Variation ID: 222939). For these reasons, this variant has been classified as Pathogenic. |